Diplomat Pharmacy (DPLO) Misses Q1 EPS by 26c, Revenues Beat; Offers FY19 EPS Views Below Consensus, FY19 Revenue Mid-Point Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Diplomat Pharmacy (DPLO) Misses Q1 EPS by 26c, Revenues Beat; Offers FY19 EPS Views Below Consensus, FY19 Revenue Mid-Point Guidance Above Consensus

Diplomat Announces 1st Quarter Financial Results

May 7, 2019 7:30 AM EDT

FLINT, Mich., May 7, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended March 31, 2019.  All comparisons, unless otherwise noted, are to the quarter ended March 31, 2018.  Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative expense for our Specialty segment.  This change is a reclassification only and has no impact on overall results.

... More